Skip to content
The Nexus
HEALTHJun 5 · 12:30 UTCCROSSCUT SEATTLECascade PBS Staff

A New Pill Finally Offers Hope for Pancreatic Cancer

A new daily pill for pancreatic cancer has shown to reduce the risk of death by 60% compared to chemotherapy in a study involving 500 patients. The drug, developed by a biotech company, is doubling survival time for patients with an aggressive form of the disease.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Dr. Mark Goldsmithpersonbiotech companyorganizationpancreatic cancertopicchemotherapytopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting